850101 | 13:0 Lyso PI
1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt)

Info
13:0 Lyso PI
1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt)
Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.
Data
No
No
C22H46NO12P
C 48.26%, H 8.47%, N 2.56%, O 35.06%, P 5.66%
>99% LPI; may contain up to 10% of the 2-LPI isomer
1 Years
-20°C
CAS Number
1223078-83-8
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
547.574
547.276
PI(13:0/0:0)
110716
110716
References
Iaea DB, Spahr ZR, Singh RK, Chan RB, Zhou B, Bareja R, Elemento O, Di Paolo G, Zhang X, Maxfield FR. Stable reduction of STARD4 alters cholesterol regulation and lipid homeostasis. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Apr;1865(4):158609. doi: 10.1016/j.bbalip.2020.158609. Epub 2020 Jan 7. PMID: 31917335; PMCID: PMC6996790.
PubMed ID: 31917335Miranda AM, Bravo FV, Chan RB, Sousa N, Di Paolo G, Oliveira TG. Differential lipid composition and regulation along the hippocampal longitudinal axis. Transl Psychiatry. 2019 Apr 26;9(1):144. doi: 10.1038/s41398-019-0478-6.
PubMed ID: 31028243
Certificates of Analysis
- Certificate of Analysis (Lot No. 850101P-100UG-C-010 and 5587PDC010)
- Certificate of Analysis (Lot No. 850101P-500UG-A-010 and 5587PFA010)
- Certificate of Analysis (Lot No. 850101P-500UG-A-010 and 5587PFA010)
- Certificate of Analysis (Lot No. 850101P-100UG-D-010 and 5587PDD010)
- Certificate of Analysis (Lot No. 850101P-500UG-D-010 and 5587PFD010)
- Certificate of Analysis (Lot No. 850101P-100UG-C-010 and 5587PDC010)